TNF Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equity (Details Narrative)

Equity (Details Narrative) - $ / shares		6 Months Ended
Equity (Details Narrative) - $ / shares	Feb. 21, 2023	Jun. 30, 2024	Jul. 25, 2024	Jul. 24, 2024	Jun. 17, 2024	May 20, 2024	Apr. 05, 2024	Mar. 04, 2024	Feb. 14, 2024	Feb. 13, 2024	Dec. 31, 2023	Feb. 28, 2023
Class of Stock [Line Items]
Common stock shares authorized		250,000,000							66,666,666	550,000,000	250,000,000
Capital units authorized		300,000,000
Common stock par value		$ 0.001						$ 0.001			$ 0.001
Preferred stock shares authorized		50,000,000									50,000,000
Preferred stock par value		$ 0.001									$ 0.001
Common stock, shares issued		2,370,423									2,018,857
Common stock, shares outstanding		2,370,423									2,018,857
Preferred stock, terms of conversion		The Series F-1 Preferred Stock cannot be converted to Common Stock if the holder and its affiliates would beneficially own more than 4.99% or 9.99% at the election of the holder of the outstanding Common Stock. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99% upon notice to us, provided that any increase in this limitation will not be effective until 61 days after such notice from the holder to us and such increase or decrease will apply only to the holder providing such notice.
Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Preferred stock, stated value						$ 1,000
Warrant exercise price						1.816
Securities Purchase Agreement [Member] \| Investors [Member]
Class of Stock [Line Items]
Preferred stock par value	$ 3.18
Conversion price per share	$ 1.816
Warrants to purchase common stock	4,716,904											4,716,904
Warrant exercise price	$ 2.255											$ 3.18
Common Stock [Member]
Class of Stock [Line Items]
Common stock, shares issued		2,370,423									2,018,857
Common stock, shares outstanding		2,370,423									2,018,857
Underlying shares		1,217
Share price		$ 1.84									$ 7.77
Common Stock [Member] \| Securities Purchase Agreement [Member] \| Investors [Member]
Class of Stock [Line Items]
Warrants to purchase common stock												4,716,904
Series G Preferred Stock [Member]
Class of Stock [Line Items]
Temporary stock, shares authorized		12,826,273
Preferred stock, shares issued		8,950									0
Preferred stock outstanding shares		8,950									0
Preferred stock, terms of conversion		The Series G Preferred Stock cannot be converted to Common Stock if the holder, other than PharmaCyte Biotech, Inc., and its affiliates would beneficially own more than 4.99% or 9.99% at the election of the holder of the outstanding Common Stock. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99% upon notice to us, provided that any increase in this limitation will not be effective until 61 days after such notice from the holder to us and such increase or decrease will apply only to the holder providing such notice.
Dividend rate		10.00%
Series G Preferred Stock [Member] \| Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Preferred stock par value						$ 0.001
Series G Preferred Stock [Member] \| Securities Purchase Agreement [Member] \| Investors [Member]
Class of Stock [Line Items]
Conversion price per share		$ 1.816
Warrant exercise price	1.816
Series C Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock shares authorized		1,990,000
Common stock, shares issued		918									918
Common stock, shares outstanding		918									918
Series D Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock shares authorized		211,353									211,353
Preferred stock par value		$ 0.001									$ 0.001
Preferred stock, shares issued		72,992									72,992
Preferred stock outstanding shares		72,992									72,992
Preferred stock, stated value		$ 0.01									$ 0.01
Conversion price per share		$ 0.01
Conversion of stock description		A holder of Series D Preferred Stock is prohibited from converting Series D Preferred Stock into shares of Common Stock if, as a result of such conversion, the holder, together with its affiliates, would own more than 4.99% of the total number of shares of our Common Stock then issued and outstanding (with such ownership restriction referred to as the “Series D Beneficial Ownership Limitation”) immediately after giving effect to the issuance of the shares of Common Stock issuable upon conversion of the Series D Preferred Stock. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61 days after such notice to us. The conversion rate of the Series D Preferred Stock is subject to proportionate adjustments for stock splits, reverse stock splits and similar events, but is not subject to adjustment based on price anti-dilution provisions
Description of trading activities		If the Company fails to timely deliver shares of Common Stock upon conversion of the Series D Preferred Stock (the “Series D Conversion Shares”) within the time period specified in the Series D Certificate of Designation (within two trading days after delivery of the notice of conversion, or any shorter standard settlement period in effect with respect to trading market on the date notice is delivered), then the Company is obligated to pay to the holder, as liquidated damages, an amount equal to $25 per trading day (increasing to $50 per trading day on the third trading day and $100 per trading day on the sixth trading day) for each $5,000 of stated value of Series D Preferred Stock being converted which are not timely delivered. If the Company makes such liquidated damages payments, the Company is also not obligated to make Series D Buy-In (as defined below) payments with respect to the same Series D Conversion Shares
Series E Junior Participating Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock shares authorized		100,000
Series F Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Temporary stock, shares authorized		15,000									15,000
Conversion price per share	$ 2.255
Conversion of stock description		If on any day after the issuance of the shares of Series F Preferred Stock the closing price of the Common Stock has exceeded $6.765 (as adjusted for the Reverse Stock Split) (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other similar events) for 20 consecutive trading days and the daily dollar trading volume of the Common Stock has exceeded $3,000,000 per trading day during the same period and certain equity conditions described in the Series F Certificate of Designation are satisfied (the “Mandatory Conversion Date”), the Company shall deliver written notice of the Mandatory Conversion (as defined below) to all holders on the Mandatory Conversion Date and, on such Mandatory Conversion Date, the Company shall convert all of each holder’s shares of Series F Preferred Stock into Conversion Shares at the then effective Conversion Price (the “Mandatory Conversion”). If any of the Equity Conditions shall cease to be satisfied at any time on or after the Mandatory Conversion Date through and including the actual delivery of all of the Conversion Shares to the holders, the Mandatory Conversion shall be deemed withdrawn and void ab initio
Preferred stock, terms of conversion		The Series F Preferred Stock cannot be converted to Common Stock if the holder and its affiliates would beneficially own more than 4.99% or 9.99% at the election of the holder of the outstanding Common Stock. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99% upon notice to us, provided that any increase in this limitation will not be effective until 61 days after such notice from the holder to us and such increase or decrease will apply only to the holder providing such notice
Dividend rate	10.00%
Number of shares issued							$ 6.765
Series F Preferred Stock [Member]
Class of Stock [Line Items]
Temporary stock, shares authorized		5,050
Preferred stock, shares issued		4,675									6,633
Preferred stock outstanding shares		4,675									6,633
Stock Issued During Period, Shares, New Issues		350,658
Series F Preferred Stock [Member] \| Securities Purchase Agreement [Member] \| Investors [Member]
Class of Stock [Line Items]
Preferred stock par value	$ 1.816
Warrant exercise price	1.816
Series F 1 Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares issued		5,050									0
Preferred stock outstanding shares		5,050									0
Conversion of stock description		If on any day after the issuance of the shares of Series F-1 Preferred Stock the closing price of the Common Stock has exceeded $5.448 per share (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other similar events) for 20 consecutive trading days and the daily dollar trading volume of the Common Stock has exceeded $3,000,000 per trading day during the same period and certain equity conditions described in the Series F-1 Certificate of Designation are satisfied (the “Mandatory Conversion Date”), the Company shall deliver written notice of the Mandatory Conversion (as defined below) to all holders on the Mandatory Conversion Date and, on such Mandatory Conversion Date, the Company shall convert all of each holder’s shares of Series F-1 Preferred Stock into Conversion Shares at the then effective Conversion Price (the “Mandatory Conversion”). If any of the Equity Conditions shall cease to be satisfied at any time on or after the Mandatory Conversion Date through and including the actual delivery of all of the Conversion Shares to the holders, the Mandatory Conversion shall be deemed withdrawn and void ab initio
Dividend rate		10.00%
Series F 1 Preferred Stock [Member] \| Measurement Input, Default Rate [Member]
Class of Stock [Line Items]
Dividend rate		15.00%
Series F Warrant [Member] \| Securities Purchase Agreement [Member] \| Investors [Member]
Class of Stock [Line Items]
Number of shares issued												$ 1.816
Minimum [Member]
Class of Stock [Line Items]
Common stock shares authorized			16,666,666
Minimum [Member] \| Series G Preferred Stock [Member]
Class of Stock [Line Items]
Common stock shares authorized					8,950
Conversion price per share		$ 2.253
Minimum [Member] \| Series F Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Conversion price per share	$ 60.21	60.21
Minimum [Member] \| Series F 1 Preferred Stock [Member]
Class of Stock [Line Items]
Conversion price per share		$ 2.253
Minimum [Member] \| Subsequent Event [Member]
Class of Stock [Line Items]
Common stock shares authorized				16,666,666
Maximum [Member]
Class of Stock [Line Items]
Common stock shares authorized									250,000,000
Maximum [Member] \| Series G Preferred Stock [Member]
Class of Stock [Line Items]
Common stock shares authorized					12,826,273
Maximum [Member] \| Subsequent Event [Member]
Class of Stock [Line Items]
Common stock shares authorized				250,000,000